Interrelation between endogenous intoxication indicators and nitric oxide metabolites in the infectious process in chronic viral hepatitis C

Cover Page


Cite item

Abstract

Aim. To study dynamics and interrelation between final nitric oxide metabolites (nitrites) and endogenous intoxication index (medium mass molecules) in patients with chronic hepatitis C with the effect of antiviral therapy on them.

Methods. The study included 99 patients with chronic hepatitis C. The combination therapy for 48 weeks in patients with genotype 1 chronic hepatitis C with pegylated interferon (peginterferon alfa-2a and alfa-2b) in combination with ribavirin and for 24 weeks with daily standard interferon alfa-2b administration in patients with virus genotypes 2 and 3 was conducted. The nitric oxide level was estimated by the content of the nearest metabolite (nitrite) in blood serum using the P.P. Golikov method. Medium mass molecules in the blood serum were determined by the N.I. Gabrielyan method.

Results.In patients with chronic hepatitis C high values of nitrogen oxide metabolites and the medium mass molecules in the blood serum were revealed, whereas the level of nitroxidemia and endogenous intoxication by the values of medium mass molecules was associated with the viral replicative capacity value and alanine aminotransferase serum levels. Amid the combination antiviral therapy the nature of nitroxidergy changed with the normalization of nitrogen oxide indicators by 24 weeks and an increase to 48 weeks of treatment. There were significantly positive correlative relations between pronouncement of levels of nitric oxide metabolites and the medium mass molecules before the start of antiviral therapy (R=0.292629, p

Conclusion. Chronic hepatitis C promotes increase in nitrite ion content and medium mass molecules in the blood serum, their level is associated with virus replication activity and cytolysis severity; antiviral therapy has an effect on the level of endogenous intoxication with the normalization of content of the nitrite ions and medium mass molecules in blood serum by 24th week of treatment.

About the authors

N V Galeeva

Kazan State Medical University

Author for correspondence.
Email: Nelli_04@mail.ru

V Kh Fazylov

Kazan State Medical University

Email: Nelli_04@mail.ru

I Kh Valeeva

Kazan State Medical University

Email: Nelli_04@mail.ru

References

  1. Булатова И.А., Щекотова А.П., Третьякова Ю.И. Дисфункция эндотелия при хронических диффузных заболеваниях печени. Казанский мед. ж. 2009; 90 (1): 46-48.
  2. Виноградов Н.А. Синтез окиси азота в организме больных вирусными гепатитами. Антибиотики и химиотерап. 2001; 6 (4): 26-28.
  3. Голиков И.П. Оксид азота в клинике неотложных заболеваний. М.: Медпрактика-М. 2004; 186 с.
  4. Габриэлян Н.И., Липатова В.И. Опыт использования показателя средних молекул крови для диагностики неврологических заболеваний у детей. Лабораторн. дело. 1984; (3): 138-141.
  5. Карякина Е.В., Белова С.В. Молекулы средней массы как интегральный показатель метаболических нарушений (обзор литературы). Клин. лаб. диагностика. 2004; (3): 3-8.
  6. Лебедев В.В., Бондаренко И.Н., Авдеева М.Г. и др. Клиническое значение уровня оксида азота в дифференциальной диагностике острых, хронических вирусных и токсических поражений печени. Инфекц. болезни. 2010; 8 (1): 19-24.
  7. Нагоев Б.С., Габрилович И.Н., Кимова И.А. Молекулы средней массы плазмы при вирусных гепатитах. Терап. арх. 1998; (11): 26-29.
  8. Ратникова Л.И., Мельников И.В. Значение оксида азота в повреждении гепатоцитов при патологии печени. Эпидемиол. и инфекц. бол. 2002; (6): 50-54.
  9. Скляр Л.Ф., Маркелова Е.В., Полушин О.Г. и др. Хроническая HCV-инфекция: современные иммуноморфологические аспекты. М.: Издательство российского университета дружбы народов. 2006; 214 с.
  10. Тейлор Б.С., Аларсон Л.Х., Биллиар Т.Г. Индуцибельная синтаза оксида азота в печени: регуляция и функция. Биохимия. 1998; 7: 903-923.
  11. Щекотова А.П., Булатова И.А., Мутагаров И.Н. Оксид азота - тест дифференциальной диагностики хронического гепатита и цирроза печени. Международ. ж. прикладн. и фундамент. исслед. 2012; (3): 39-41.
  12. Chang K.M. Immunopathogenesis of hepatitis C virus infection. Clin. Liver Dis. 2003; (7): 89-105. http://dx.doi.org/10.1016/S1089-3261(02)00068-5
  13. Kane J.M., Shears L.L., Hierholzer C. et al. Chronic hepatitis C virus infection in humans - Induction of hepatic nitric oxide synthase and proposed mechanisms for carcinogenesis J. Surg. Res. 1997; 69 (2): 321-324. http://dx.doi.org/10.1006/jsre.1997.5057
  14. Singh S., Evans T.W. Nitrieoxide, the biological mediator of the decade: fact or fiction? Eur. Respir. J. 1997; 10: 699-707.

© 2016 Galeeva N.V., Fazylov V.K., Valeeva I.K.

Creative Commons License

This work is licensed
under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.





This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies